In today’s podcast episode, we discuss the main takeaways from Meta’s landmark trial over kids and social media addiction, the safety features it plans to roll out, whether this makes a teen social media ban more or less likely, what we know about social media’s role in youth mental health, and what could change as a result of the settlement. Join Senior Director of Podcasts and host Marcus Johnson, along with Senior Analyst Beth Snyder Bulik and Analyst Marisa Jones. Listen wherever you get your podcasts, or watch on YouTube or Spotify.
Trusted healthcare providers give marketers a credible route to reach anxious patients and encourage action.
That presents an opportunity for retailers with sharp size planning.
Pharma brands and marketers can reduce prescription abandonment by clarifying benefits, expectations, and savings options.
This FAQ covers who influences the wellness shopper, where they buy, and how brands should market responsibly in 2026.
The agency is expediting reviews to help manufacturers boost estradiol patch supplies and limit treatment interruptions as HRT demand rises.
Ads drove 95% more engagement than primetime, helping new drugs break through and older brands stay effective.
Pharma marketers need relevant, digital-friendly messaging that respects HCPs’ heavy workloads.
Viewers skew older, but adults ages 35 to 54 report the strongest purchase intent for brands advertised there.
The most-favored-nation framework extends to nine midsize drugmakers, tying more US pricing decisions to what other countries pay.
Nearly a quarter of physicians (23%) say patients ask them for guidance on using wearable data to manage their health at least once a week, according to a March survey from the American Medical Association.
Gen Z and millennials’ self-care and wellness spending intentions are strong, but their budgets could change, meaning brands must demonstrate tangible value.
Pharma and providers need to help women better understand common overlooked symptoms to make more informed treatment decisions.
Nurses gives healthcare and pharma marketers a credible way to make health content accessible.
Healthcare providers need clearer explanations and consent based on how AI affects care decisions and ongoing treatment.
The deal could set stricter expectations for age checks and outside oversight across social media and tech platforms.
New, affordable GLP-1 access for Medicare beneficiaries creates an opening for marketers to address seniors’ specific weight loss needs.
RevMed’s newly approved drug nearly doubles median survival in Stage 4 pancreatic cancer, showing that a less-established biotech can succeed where larger drugmakers have struggled.
11% of US adults currently use a GLP-1 medication, up from just 3% two years earlier, according to a July report from Gallup.
As employer health costs climb, reduced coverage for weight loss drugs will expand the self-pay GLP-1 market and intensify price competition among drugmakers.